|
Basic Characteristics of Mutations
|
|
Mutation Site
|
A9T |
|
Mutation Site Sentence
|
Table 7 |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
UL30 |
|
Standardized Encoding Gene
|
UL30
|
|
Genotype/Subtype
|
- |
|
Viral Reference
|
NC_001798.2
|
|
Functional Impact and Mechanisms
|
|
Disease
|
HSV-2 Infection
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
- |
|
Location
|
Korea |
|
Literature Information
|
|
PMID
|
37632051
|
|
Title
|
Variant Analysis of the Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus in Korea: Frequency of Acyclovir Resistance Mutations
|
|
Author
|
Hyun J,Lee SK,Kim JH,Cho EJ,Kim HS,Kim JS,Song W,Kim HS
|
|
Journal
|
Viruses
|
|
Journal Info
|
2023 Aug 9;15(8):1709
|
|
Abstract
|
The thymidine kinase (TK) and DNA polymerase (pol) genes of the herpes simplex viruses type 1 (HSV-1) and type 2 (HSV-2) are two important genes involved in antiviral resistance. We investigated the genetic polymorphisms of the HSV-TK and pol genes in clinical isolates from Korean HSV-infected patients using next-generation sequencing (NGS) for the first time in Korea. A total of 81 HSV-1 and 47 HSV-2 isolates were examined. NGS was used to amplify and sequence the TK and pol genes. Among the 81 HSV-1 isolates, 12 and 17 natural polymorphisms and 9 and 23 polymorphisms of unknown significance in TK and pol were found, respectively. Two HSV-1 isolates (2.5%) exhibited the E257K amino acid substitution in TK, associated with antiviral resistance. Out of 47 HSV-2 isolates, 8 natural polymorphisms were identified in TK, and 9 in pol, with 13 polymorphisms of unknown significance in TK and 10 in pol. No known resistance-related mutations were observed in HSV-2. These findings contribute to our understanding of the genetic variants associated with antiviral resistance in HSV-1 and HSV-2 in Korea, with frequencies of known antiviral resistance-related mutations of 2.5% and 0% in HSV-1 and HSV-2, respectively.
|
|
Sequence Data
|
-
|
|
|